• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,245.91 45.04
(0.09%)
Dow Jones
7,786.38 -36.39
(-0.47%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.67 0.30
(0.31%)
EUR-INR
108.31 -0.02
(-0.02%)
GBP-INR
127.86 0.18
(0.14%)
JPY-INR
0.61 0.00
(0.24%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
35.81
2967.37
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
2.02
 

shah metacorp ltd
XT Global Infotech consolidated net profit rises 408.47% in the March 2026 quarter
May 27,2026
Net profit of XT Global Infotech rose 408.47% to Rs 3.00 crore in the quarter ended March 2026 as against Rs 0.59 crore during the previous quarter ended March 2025. Sales rose 2.84% to Rs 89.52 crore in the quarter ended March 2026 as against Rs 87.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.01% to Rs 11.53 crore in the year ended March 2026 as against Rs 9.15 crore during the previous year ended March 2025. Sales rose 57.48% to Rs 368.72 crore in the year ended March 2026 as against Rs 234.14 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.5287.05 3 368.72234.14 57
OPM %4.805.00 -7.199.58 -
PBDT3.573.31 8 23.5921.17 11
PBT2.071.38 50 17.1713.31 29
NP3.000.59 408 11.539.15 26